Lv1
20 积分 2024-02-23 加入
The FMO3/TMAO/HSP90β axis aggravates MAFLD by disrupting mitochondrial protein homeostasis
13天前
已完结
TMAO regulates OTUB1-mediated SLC7A11 stability to promote NAFLD progression
2个月前
已完结
The effect of TMAO on aging-associated cardiovascular and metabolic pathways and emerging therapies
2个月前
已完结
Selection and Dosing of Medications for Management of Diabetes in Patients with Advanced Kidney Disease
2个月前
已完结
[Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)]
2个月前
已完结
Liver aging: underlying mechanisms and therapeutic strategies
2个月前
已完结
FMO3 exacerbates hepatic endoplasmic reticulum stress in drug-induced liver injury by inhibiting CREB3/P4HB axis and activating TMAO-mediated PERK pathway
2个月前
已完结
Trimethylamine N-oxide promotes hyperoxaluria-induced calcium oxalate deposition and kidney injury by activating autophagy
2个月前
已完结
FMO3 exacerbates hepatic endoplasmic reticulum stress in drug-induced liver injury by inhibiting CREB3/P4HB axis and activating TMAO-mediated PERK pathway
4个月前
已完结
Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
5个月前
已完结
皖公网安备34019202002308
